Abstract:Hypoxic areas are present in the majority of solid tumors, and hypoxia is associated with resistance to therapies and poor outcomes. A transmembrane protein that is upregulated by tumor cells that have adapted to hypoxic conditions is carbonic anhydrase IX (CAIX). Therefore, noninvasive imaging of CAIX could be of prognostic value, and it could steer treatment strategies. The aim of this study was to compare variants of CAIX-binding VHH B9, with and without a C-terminal albumin-binding domain with varying affinity (ABDlow and ABDhigh), for SPECT imaging of CAIX expression. The binding affinity and internalization of the various B9-variants were analyzed using SK-RC-52 cells. Biodistribution studies were performed in mice with subcutaneous SCCNij153 human head and neck cancer xenografts. Tracer uptake was determined by ex vivo radioactivity counting and visualized by SPECT/CT imaging. Furthermore, autoradiography images of tumor sections were spatially correlated with CAIX immunohistochemistry. B9-variants demonstrated a similar moderate affinity for CAIX in vitro. Maximal tumor uptake and acceptable tumor-to-blood ratios were found in the SCCNij153 model at 4 h post injection for [111In]In-DTPA-B9 (0.51 ± 0.08%ID/g and 8.1 ± 0.85, respectively), 24 h post injection for [111In]In-DTPA-B9-ABDlow (2.39 ± 0.44%ID/g and 3.66 ± 0.81, respectively) and at 72 h post injection for [111In]In-DTPA-B9-ABDhigh (8.7 ± 1.34%ID/g and 2.43 ± 0.15, respectively). An excess of unlabeled monoclonal anti-CAIX antibody efficiently inhibited tumor uptake of [111In]In-DTPA-B9, while only a partial reduction of [111In]In-DTPA-B9-ABDlow and [111In]In-DTPA-B9-ABDhigh uptake was found. Immunohistochemistry and autoradiography images showed colocalization of all B9-variants with CAIX expression; however, [111In]In-DTPA-B9-ABDlow and [111In]In-DTPA-B9-ABDhigh also accumulated in non-CAIX expressing regions. Tumor uptake of [111In]In-DTPA-B9-ABDlow and [111In]In-DTPA-B9-ABDhigh, but not of [111In]In-DTPA-B9, could be visualized with SPECT/CT imaging. In conclusion, [111In]In-DTPA-B9 has a high affinity to CAIX and shows specific targeting to CAIX in head and neck cancer xenografts. The addition of ABD prolonged plasma half-life, increased tumor uptake, and enabled SPECT/CT imaging. This uptake was, however, partly CAIX- independent, precluding the ABD-tracers for use in hypoxia quantification in this tumor type.

Application of carbonic anhydrase IX in sporadic hemangioblastoma of the central nervous system and hemangioblastoma associated with von Hippel-Lindau disease

Immunohistochemical Reevaluation of Carbonic Anhydrase IX (CA IX) Expression in Tumors and Normal Tissues.

Biom-17. Evaluation Of Carbonic Anhydrase Type Ix (Ca Ix) Expression As Target For Radioligand Therapy In Glioblastoma

Overexpression of MAGE-A9 predicts unfavorable outcome in breast cancer.

Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapy

Carbonic anhydrase IX stratifies patient prognosis and identifies nodal status in animal models of nasopharyngeal carcinoma using a targeted imaging strategy

Carbonic anhydrase Ⅸ and tumor

Identification of Carbonic Anhydrase IX As a Novel Target for Endoscopic Molecular Imaging of Human Bladder Cancer.

Prognostic value of carbonic anhydrase IX expression in penile squamous cell carcinoma: a pilot study

Carbonic anhydrase IX as a novel candidate in liquid biopsy

Expression of CXCR4 and VEGF in Hemangioblastomas of the Central Nervous System and Its Relation to Tumor Angiogenesis

Oncogenic Roles of Carbonic Anhydrase IX in Human Nasopharyngeal Carcinoma.

Expression of hypoxia-related carbonic anhydrase-9 in colorectal carcinoma and its biological significance

Overexpression of EGFR and TGFα in Von Hippel–Lindau-Related Central Nervous System Hemangioblastomas

Association Between Carbonic Anhydrase 9 Expression and Poor Prognosis in Sinonasal Squamous Cell Carcinoma

Immunohistochemical Study on Central Nervous System Cavernous Hemangiomas

Imaging of CA IX with fluorescent labelled sulfonamides distinguishes hypoxic and (re)-oxygenated cells in a xenograft tumour model

Expression and Significance of Carbonic Anhydrases IX and Vascular Endothelial Growth Factors in Bladder Transitional Cell Carcinoma

The role of AQP-1 and VEGF in the formation of hemangioblastomas

Novel VHH-Based Tracers with Variable Plasma Half-Lives for Imaging of CAIX-Expressing Hypoxic Tumor Cells

Hypoxia-regulated carbonic anhydrase IX (CAIX) protein is an independent prognostic indicator in triple negative breast cancer